Revealed: Active Pharmaceutical Ingredient CDMO Market Poised for Significant Transformation Ahead
The evolution of the Active Pharmaceutical Ingredient CDMO Market is marked by a compelling mix of innovation and demand-driven dynamics. Expected to reach a market size of USD 21.76 billion by 2035, the sector is experiencing a steady growth trajectory with a CAGR of 3.97%. This growth is largely attributed to the increasing prevalence of chronic diseases, which now accounts for over 50% of...
0 Commenti
0 condivisioni
14 Views